Head of HIV pathogenesis and vaccine research at CAPRISA - own views
Dec 22, 2021 • 4 tweets • 2 min read
A few #Sisonke study updates. There are three pre-print publications out now, for those interested: 1. Effectiveness data on the single dose JnJ Ad26.COV2.S vaccine 2. Safety of the JnJ vaccine and 3. Breakthrough infections during Omicron wave @CAPRISAOfficial@MRCza@HealthZA1. Effectiveness: VE to prevent deaths 83%, ITU admissions 75% and hospitalisations 67%. VE maintained for older HCWs, those with comorbidities or living with HIV, through beta and delta waves papers.ssrn.com/sol3/papers.cf…